Page 1685 - Clinical Small Animal Internal Medicine

Index 1623

NFkappaB see nuclear factor kappa B ocular Mycoplasma infections in nucleoside analogs 875
VetBooks.ir NICTH see nonislet tumor‐induced public health implications 934 critical care setting 352
nursing care
nicotinic acetylcholine receptors
cats 932–933
(nAChR) 803–807
respiratory Mycoplasma infections in
mechanical ventilation
hypoglycemia cats/dogs 933 398–400, 402
nitric oxide signalment 932 surgical approaches to thoracic
pulmonary hypertension 225 treatment 934 disease 329
pulmonary thromboembolism 320 urogenital Mycoplasma infections in trauma and burns 454–455
septic shock 423 dogs 933 nutrient artery 1513
nitrogen wash‐out 325 non‐immune complex‐mediated nutrition see diet and nutrition
NLE see necrotizing leukoencephalitis glomerulonephritis NYHA see New York Heart Association
NME see necrotizing (non‐ICGN) 1101 nystagmus 738, 791
meningoencephalitis noninfectious vaccines 1568
NMJ see neuromuscular junction nonislet tumor‐induced hypoglycemia o
diseases (NICTH) 106–107 OA see osteoarthritis
nocardiosis 979–980 nonmaleficence principle OAB see overactive bladder
diagnosis 979 1561–1563 obesity
epidemiology 979 nonmelanoma skin cancers cardiovascular disease 128
etiology/pathophysiology 979 1353–1357 diabetes mellitus 93–94
history and clinical signs 979 diagnosis 1355–1356 osteoarthritis 1532–1533
public health implications 980 epidemiology 1353–1355 obstipation 612–613
signalment 977, 979 etiology/pathophysiology 1353 obstructive uropathy see ureteral
treatment and prognosis history and clinical signs 1355 obstruction; urethral obstruction
979–980 prognosis 1357 OC see osteochondrosis
nocosomial and multidrug‐resistant signalment 1355 OCD see osteochondrosis dissecans
infections 1057–1062 treatment 1356–1357 ocular adnexal tumors 1261–1264
antimicrobials 1045–1047, 1060 nonparametric analysis 10, 11, 25 diagnosis 1262
cleaning and disinfection 1061 nonpyogenic hypothermia 295 eyelids, third eyelid,
colonization versus infection 1061 nonregenerative normocytic conjunctiva, and cornea
concepts and definitions 1057 normochromic anemia 1261–1262, 1262
hand hygiene and contact 1241–1242 history and clinical signs 1262
precautions 1061 nonsteroidal antiinflammatory drugs limbal/epibulbar melanoma
identification of hospital‐acquired (NSAID) 1263–1264
infections 1057 developmental orthopedic prognosis 1263, 1269
management 1060–1062, 1060 diseases 1540, 1542–1545, secondary orbital tumors 1269
pathogens of concern 1059–1060 1548–1550 treatment 1262–1263
patient housing 1061 endoscopy 513, 518–519 ocular decontamination 441
presentations and risk fever 435–436 ocular Mycoplasma infections
factors 1058 gastritis and gastric ulceration 932–933
zoonotic infections 1061–1062 549–550, 552–553 ocular posttraumatic sarcoma 1266
nodular dermatofibrosis 1489 intestinal cancers 1287, 1291 oculocephalic reflex 753
nodules 1384, 1466 nonmelanoma skin cancers odds/odds ratios 15–16, 22
nonhemotropic Mycoplasma, 1356–1357 odontogenic tumors and cysts
Ureaplasma, and L‐form osteoarthritis 1533 538–539
bacteria 931–935 septic shock 424–425 ODS see osmotic demyelination
abscesses and cellulitis in cats 934 skeletal development and syndrome
arthritis in cats/dogs caused by homeostasis 1518 OER see oxygen extraction ratio
mycoplasmas 933 toxic diseases of the liver 684 OG see osmole gap
CNS Mycoplasma infections in cats/ trauma and burns 452 ointments 1398, 1469
dogs 933 venomous snake bites 464 olfactory glial cell transplantation
diagnosis 934, 934 NT‐proBNP see B‐type natriuretic 746
epidemiology 931–932 peptide oligodendrogliomas 779–780
etiology 931, 932 nuclear factor kappa B oliguria 1177–1178
history and clinical signs (NFkappaB) 31 omega 3 fatty acids see polyunsaturated
932–934 nuclear scintigraphy see scintigraphy fatty acids